Personalized RNA Vector Therapy for Dystrophinopathy (Becker/DMD)
Official title: (Project 2) Development of U7snRNA Vectors for Dystrophinopathy
Funded at Research Inst Nationwide Children's Hosp · NIH-11397455 · Data updated 2026-11-12
A patient-friendly look at a project that aims to customize a genetic therapy to help people with Duchenne/Becker muscular dystrophy using AAV-delivered RNA to restore dystrophin.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Research Inst Nationwide Children's Hosp NIH-funded |
| Lab location | 1 site (Columbus, United States) |
| Project start | August 15, 2024 |
| Project end | July 31, 2028 |
| Funding year | 2026 |
| Award (this year) | $317,473 |
| NIH project number | 5P50HD117373-03 |
| Project ID | NIH-11397455 on NIH RePORTER |
Who could benefit from this research
✓Could help
Patients with DMD or BMD whose mutations could benefit from exon-skipping or bespoke dystrophin restoration approaches.
✕Less likely to help
Patients with mutations unlikely to respond to exon-skipping strategies or those who cannot receive AAV-based therapy due to safety concerns.
What this research studies
This project seeks to develop vectors that optimize RNA splice changes to produce functional dystrophin and hopefully improve outcomes for individuals with DMD or BMD. Researchers plan to tailor exon-skipping approaches so the therapy could work across a range of mutations, including rare single-exon duplications. The work builds on mouse data and early patient-derived information to push toward a more universally effective treatment, potentially translating into bespoke or broader therapies depending on the mutation. The grant supports a long-term goal of delivering safe and effective vector-based exon skipping that could reduce disease severity and improve quality of life for patients.
Why it matters
Potential benefit: If successful, this approach could provide more effective, mutation-tailored therapies that enhance dystrophin expression and functional outcomes for people with Duchenne/Becker muscular dystrophy.
How similar studies have gone: Related exon-skipping strategies have shown promise in animal models and earlier studies, but broadly effective human translation remains an active area of research.
Where this research is happening
-
Research Inst Nationwide Children's Hosp
Columbus, United States Active
Researchers
- Principal investigator: Flanigan, Kevin M — Research Inst Nationwide Children's Hosp
- Study coordinator: Flanigan, Kevin M
Related research
Other NIH-funded projects on the same topics.
-
A center focused on immunotherapy for pediatric cancers.
This study is exploring new ways to use the body's immune system to fight childhood cancers, aiming to create better treatments for kids whose cancers haven't responded well to standard therapies.
-
Atomoxetine for MC4R obesity in children
A trial tests whether an ADHD drug, atomoxetine, can help children with a genetic form of obesity caused by MC4R mutations.
-
Collaborative Pediatric Critical Care Network: Clinical Site
A nationwide network study aims to tailor sepsis treatment for children with organ failure based on each child’s immune profile.
-
How dietary fats may make platelets overactive in obesity
A study in adults with obesity will explore how saturated fats in the diet change platelet membranes and make platelets act more likely to clump and react, which could affect heart and blood vessel health.
-
Understanding how environment and microbiome affect health in children with sickle cell disease
A research project will explore how environmental exposures shape immune responses and airway microbiomes in children with sickle cell disease and how these factors relate to health outcomes.
-
Pediatric cancer biospecimen bank and research collaboration fund
This grant supports the Children’s Oncology Group to collect, bank, and share tumor and other biospecimens from children and adolescents with cancer for research.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.